Page 29 - Roivant Sciences News Today

IMVT-1402 subcutaneous doses achieved peak Immunoglobulin G reductions that are similar to those previously observed with batoclimabNo decrease in serum albumin below baseline or increase in...

Republican presidential candidates will debate for a second time on Sept. 27 at the Ronald Reagan Presidential Library.

Stock index futures pointed to a lower open on Wall Street Tuesday morning.

With U.S. stock markets set to open in two hours, Roivant Sciences Ltd. (ROIV) was up 14.1% in pre-market trading, and Liberty Media Corp. Series A Sirius XM…

By Dean Seal Shares of Immunovant surged after the company disclosed positive results from a Phase 1 clinical trial of its IMVT-1402 drug candidate for...

The second GOP debate is right around the corner. These are the candidates who are set to take the stage

Wall Streets main indexes were on track for a lower open on Tuesday as investors continued to grapple with the prospects of a prolonged restrictive monetary policy by the Federal Reserve and its...

Shares of Immunovant surged over 60% in premarket trading on Tuesday, after the drug developer said its antibody treatment succeeded in an early-stage trial. Immunovants experimental...

The second Republican debate is this Wednesday. Here is who will be there

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $10.21, but opened at $11.80. Roivant Sciences shares last traded at $12.21, with a volume of 4,771,961 shares traded. Analyst Ratings Changes A number of research firms recently issued reports […]